Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study - Zhao, Y; Yang, L; Xiang, Y (J Clin Endocrinol Metab, 2014)
doi:10.1210/jc.2013-3633